Novo Nordisk’s Shares Are Rising Because Newer Diabetes Drugs Are Selling Well – Barron’s

The biggest insulin maker in the world had some good and not-so-great news for investors on Friday. But the bright side was winning out for Denmarks
Novo Nordisk
as shares climbed to their best level in a week.The drugmakers stock was up 1.5% after it re…

Click here to view the original article.